Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 412

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 1
Chunk 412
---

    (Principal
    Executive Officer)

    By:
    /S/
    Michelle Yanez

    Name:
    Michelle
    Yanez

    Title:
    Chief
    Financial Officer

    (Principal
    Financial Officer)

In
accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities
and on the dates indicated.

    Person
     
    Capacity
     
    Date

    /s/
    Erez Aminov
     
    Chief
    Executive Officer and Chairman
     
    February
    4, 2025
  
    Erez
    Aminov
     
    (Principal
    Executive Officer)

    /s/
    Michelle Yanez, MBA
     
    Chief
    Financial Officer
     
    February
    4 , 2025
  
    Michelle
    Yanez, MBA
     
    (Principal
    Financial Officer and Principal Accounting Officer)

    /s/
    Dr. Craig Eagle
     
    Director
     
    February
    4 , 2025
  
    Dr.
    Craig Eagle

    /s/
    Ned MacPherson.
     
    Director
     
    February
    4 , 2025
  
    Ned
    MacPherson.

    /s/
    Matthew Pratt Whalen, CPA
     
    Director
     
    February
    4 , 2025
  
    Matthew
    Pratt Whalen, CPA

    /s/
    Matthew P. Del Giudice
     
    Director
     
    February
    4 , 2025
  
    Matthew
    P. Del Giudice

75